These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31294444)

  • 21. A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1.
    Chartier A; Benoit B; Simonelig M
    EMBO J; 2006 May; 25(10):2253-62. PubMed ID: 16642034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein.
    Raz V; Routledge S; Venema A; Buijze H; van der Wal E; Anvar S; Straasheijm KR; Klooster R; Antoniou M; van der Maarel SM
    Am J Pathol; 2011 Oct; 179(4):1988-2000. PubMed ID: 21854744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the ubiquitin-proteasome system contributes to oculopharyngeal muscular dystrophy through muscle atrophy.
    Ribot C; Soler C; Chartier A; Al Hayek S; Naït-Saïdi R; Barbezier N; Coux O; Simonelig M
    PLoS Genet; 2022 Jan; 18(1):e1010015. PubMed ID: 35025870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1.
    García-Castañeda M; Vega AV; Rodríguez R; Montiel-Jaen MG; Cisneros B; Zarain-Herzberg A; Avila G
    J Physiol; 2017 Jul; 595(13):4167-4187. PubMed ID: 28303574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of
    Cruz-Aguilar M; Guerrero-de Ferran C; Tovilla-Canales JL; Nava-Castañeda A; Zenteno JC
    J Investig Med; 2017 Mar; 65(3):705-708. PubMed ID: 27980005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oculopharyngeal muscular dystrophy: phenotypic and genotypic characteristics of 9 Polish patients.
    Nadaj-Pakleza A; Richard P; Lusakowska A; Gajewska J; Jamrozik Z; Kostera-Pruszczyk A; Kwieciński H; Kamińska A
    Neurol Neurochir Pol; 2009; 43(2):113-20. PubMed ID: 19484687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing.
    Klein P; Oloko M; Roth F; Montel V; Malerba A; Jarmin S; Gidaro T; Popplewell L; Perie S; Lacau St Guily J; de la Grange P; Antoniou MN; Dickson G; Butler-Browne G; Bastide B; Mouly V; Trollet C
    Nucleic Acids Res; 2016 Dec; 44(22):10929-10945. PubMed ID: 27507886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
    Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
    Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress in understanding the pathogenesis of oculopharyngeal muscular dystrophy.
    Fan X; Rouleau GA
    Can J Neurol Sci; 2003 Feb; 30(1):8-14. PubMed ID: 12619777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis.
    Wang Q; Bag J
    Biochem Biophys Res Commun; 2006 Feb; 340(3):815-22. PubMed ID: 16378590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy.
    Galimberti V; Tironi R; Lerario A; Scali M; Del Bo R; Rodolico C; Brizzi T; Gibertini S; Maggi L; Mora M; Toscano A; Comi GP; Sciacco M; Moggio M; Peverelli L
    Eur J Neurol; 2020 Apr; 27(4):709-715. PubMed ID: 31769567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transcriptional regulation of Pabpn1 by the RNA binding protein HuR.
    Phillips BL; Banerjee A; Sanchez BJ; Di Marco S; Gallouzi IE; Pavlath GK; Corbett AH
    Nucleic Acids Res; 2018 Sep; 46(15):7643-7661. PubMed ID: 29939290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice.
    Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC
    Nat Med; 2005 Jun; 11(6):672-7. PubMed ID: 15864313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The phenotypic and genotypic features of Chinese patients with oculopharyngeal muscular dystrophy.
    Lin F; Yang K; Lin MT; Zheng FZ; Chen L; Ding YL; Ye ZX; Lin X; Wang N; Wang ZQ
    Ann Clin Transl Neurol; 2023 Mar; 10(3):426-439. PubMed ID: 36691350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dynamism of PABPN1 nuclear inclusions during the cell cycle.
    Marie-Josée Sasseville A; Caron AW; Bourget L; Klein AF; Dicaire MJ; Rouleau GA; Massie B; Langelier Y; Brais B
    Neurobiol Dis; 2006 Sep; 23(3):621-9. PubMed ID: 16860991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy.
    Richard P; Trollet C; Stojkovic T; de Becdelievre A; Perie S; Pouget J; Eymard B;
    Neurology; 2017 Jan; 88(4):359-365. PubMed ID: 28011929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.
    Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA
    Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PABPN1-Dependent mRNA Processing Induces Muscle Wasting.
    Riaz M; Raz Y; van Putten M; Paniagua-Soriano G; Krom YD; Florea BI; Raz V
    PLoS Genet; 2016 May; 12(5):e1006031. PubMed ID: 27152426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy.
    Bengoechea R; Tapia O; Casafont I; Berciano J; Lafarga M; Berciano MT
    Neurobiol Dis; 2012 Apr; 46(1):118-29. PubMed ID: 22249111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy.
    Boulinguiez A; Dhiab J; Crisol B; Muraine L; Gaut L; Rouxel C; Flaire J; Mouigni HR; Lemaitre M; Giroux B; Audoux L; SaintPierre B; Ferry A; Mouly V; Butler-Browne G; Negroni E; Malerba A; Trollet C
    J Cachexia Sarcopenia Muscle; 2024 Oct; 15(5):1976-1988. PubMed ID: 39113268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.